SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome.

• Lascano AM Division of Neurology, Department of Clinical Neuroscience, Geneva University Hospitals and University of Geneva, Faculty of Medicine, Geneva, Switzerland.
• Epiney JB Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois) and University of Lausanne, Lausanne, Switzerland.
• Coen M Service of Internal Medicine, Department of Medicine, Geneva University Hospitals and Unit of Development and Research in Medical Education (UDREM), University of Geneva, Faculty of Medicine, Geneva, Switzerland.
• Serratrice J Service of Internal Medicine, Department of Medicine, Geneva University Hospitals and Unit of Development and Research in Medical Education (UDREM), University of Geneva, Faculty of Medicine, Geneva, Switzerland.
• Bernard-Valnet R Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois) and University of Lausanne, Lausanne, Switzerland.
• Lalive PH Division of Neurology, Department of Clinical Neuroscience, Geneva University Hospitals and University of Geneva, Faculty of Medicine, Geneva, Switzerland.
• Kuntzer T Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (Centre Hospitalier Universitaire Vaudois) and University of Lausanne, Lausanne, Switzerland.
• Hübers A Division of Neurology, Department of Clinical Neuroscience, Geneva University Hospitals and University of Geneva, Faculty of Medicine, Geneva, Switzerland.

Neurology

Clinical Neurology